J Cancer 2017; 8(15):2974-2983. doi:10.7150/jca.20866 This issue Cite

Research Paper

Prognostic Significance of Host-related Biomarkers for Survival in Patients with Advanced Non-Small Cell Lung Cancer

Sookyung Lee1✉, Wankyu Eo2, Hyeonjin Jeon3, Sora Park3, Jean Chae3

1. Depart of Clinical Oncology, College of Korean Medicine, Kyung Hee University;
2. Depart of Medical Oncology and Hematology, College of Medicine, Kyung Hee University;
3. Department of Clinical Korean Medicine, Graduate School, Kyung Hee University.

Citation:
Lee S, Eo W, Jeon H, Park S, Chae J. Prognostic Significance of Host-related Biomarkers for Survival in Patients with Advanced Non-Small Cell Lung Cancer. J Cancer 2017; 8(15):2974-2983. doi:10.7150/jca.20866. https://www.jcancer.org/v08p2974.htm
Other styles

File import instruction

Abstract

Objective: This study identified host-related prognostic biomarkers for survival in patients with advanced non-small cell lung cancer (NSCLC).

Methods: This study was based on the retrospective review of the medical records of 135 patients with pathologically confirmed advanced NSCLC. The host-related biomarkers assessed in this study that reflected patient condition included hemoglobin (Hb) levels; platelet (PLT), neutrophil, lymphocyte, and monocyte counts; and ferritin concentrations. The overall survival (OS) was calculated by Kaplan-Meier analysis and compared using log-rank tests. Univariate and multivariate analyses of Cox proportional hazards regression were used to evaluate the prognostic impact for survival.

Results: Of the enrolled patients, 91.1% had stage IV NSCLC, 42.2% had ECOG-PS scores of 2, and 57% had undergone multiple rounds of prior systemic therapy. The prognostic factors included low Hb concentration (men: Hb < 13 g/dL, women: Hb < 12 g/dL; p = 0.046), increased neutrophil count (> 7,700 cells/μL; p < 0.001), decreased lymphocyte count (≤ 1500 cells/μL; p = 0.011), increased monocyte count (> 800 cells/μL; p < 0.001), and high ferritin level (men: > 200 ng/mL, women: > 150 ng/mL; p < 0.001), which were associated with poor OS and increased hazard of mortality. The multivariate proportional hazards model revealed that lymphocyte count, monocyte count, and ferritin level were independent host-related prognostic biomarkers for survival. Increased monocyte count (HR, 3.15; 95% CI, 1.64-6.04; p < 0.001) and high ferritin level (HR, 1.81; 95% CI, 1.24-2.64; p = 0.002) were significantly associated with poor survival, whereas increased lymphocyte count (HR, 0.57; 95% CI, 0.40-0.83; p = 0.004) showed prolonged survival.

Conclusion: Immune factors, such as lymphocyte and monocyte counts, as well as serum ferritin levels, are significant host-related prognostic biomarkers for survival with direct relevance to survival time in patients with advanced NSCLC.

Keywords: non-small cell lung cancer (NSCLC), prognosis, biomarkers, survival.


Citation styles

APA
Lee, S., Eo, W., Jeon, H., Park, S., Chae, J. (2017). Prognostic Significance of Host-related Biomarkers for Survival in Patients with Advanced Non-Small Cell Lung Cancer. Journal of Cancer, 8(15), 2974-2983. https://doi.org/10.7150/jca.20866.

ACS
Lee, S.; Eo, W.; Jeon, H.; Park, S.; Chae, J. Prognostic Significance of Host-related Biomarkers for Survival in Patients with Advanced Non-Small Cell Lung Cancer. J. Cancer 2017, 8 (15), 2974-2983. DOI: 10.7150/jca.20866.

NLM
Lee S, Eo W, Jeon H, Park S, Chae J. Prognostic Significance of Host-related Biomarkers for Survival in Patients with Advanced Non-Small Cell Lung Cancer. J Cancer 2017; 8(15):2974-2983. doi:10.7150/jca.20866. https://www.jcancer.org/v08p2974.htm

CSE
Lee S, Eo W, Jeon H, Park S, Chae J. 2017. Prognostic Significance of Host-related Biomarkers for Survival in Patients with Advanced Non-Small Cell Lung Cancer. J Cancer. 8(15):2974-2983.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image